Health Care & Life Sciences » Pharmaceuticals | JW Pharmaceutical Corp.

JW Pharmaceutical Corp. | Mutual Funds

Mutual Funds that own JW Pharmaceutical Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total International Stock Index Fund
163,099
0.83%
0
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
148,881
0.76%
0
0.01%
09/05/2018
Government Pension Fund - Global (The)
100,746
0.51%
25,965
0%
12/31/2017
DFA Emerging Markets Small Cap Series
70,819
0.36%
-1
0.04%
01/31/2018
Vanguard Developed Markets Index Fund
70,177
0.36%
0
0%
07/31/2018
DFA Emerging Markets Core Equity Portfolio
57,252
0.28%
8,667
0.01%
04/30/2018
Mirae Asset TIGER 200
42,137
0.21%
5,571
0.06%
01/31/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
38,559
0.2%
0
0.02%
09/05/2018
Vanguard FTSE All World (ex-US) Small Cap
30,055
0.15%
0
0.02%
07/31/2018
Mirae Asset TIGER Health Care ETF
22,381
0.11%
5,109
0.62%
04/30/2018

About JW Pharmaceutical

View Profile
Address
JW Tower
Seoul SL 06725
Korea, Republic Of
Employees -
Website http://www.jw-pharma.co.kr
Updated 07/08/2019
JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. Its products include analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, antifungal agents, circulatory system agents, gastrointestinal agents, miscellaneous, multivitamins and anti-anemic agents, contact lens care and ophthalmic agents, topicals, amino acid solutions, flexible intravenous container, intravenous solutions, respiratory agents, obstetrics and gynecology agents, nephrology agents, central nervous system, urology agents, and diabetic agents. The company was founded on August 8, 1945 and is headquartered in Seoul, South Korea.